elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q46096667-19C19ABE-DA20-4F71-AB43-D3175B8AE02B
Q46096667-19C19ABE-DA20-4F71-AB43-D3175B8AE02B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q46096667-19C19ABE-DA20-4F71-AB43-D3175B8AE02B
When the Damage Is Done: Selecting Patients for Head and Neck Cancer Chemoprevention Trials.
P2860
Q46096667-19C19ABE-DA20-4F71-AB43-D3175B8AE02B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q46096667-19C19ABE-DA20-4F71-AB43-D3175B8AE02B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8b019175e2da4b943d97089baf6310ce9b7819d5
P2860
Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial.